Market Currents
Alnylam Pharmaceuticals (ALNY +4.5%) gains after Rodman & Renshaw initiates the shares at...
-
Friday, October 14, 2011, 2:29 PM ETAlnylam Pharmaceuticals (ALNY +4.5%) gains after Rodman & Renshaw initiates the shares at market outperform on valuation, saying it has a clear technological lead and strongest patent position in the RNAi space."
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
